dapaveldactin is effective in the treatment of type II diabetes as it works to prevent the reabsorption of glucose into the blood through the kidneys and increases its exit with urine and this is a result of containing the active substance Dapagliflozin and thus shows its effectiveness in controlling the level of sugar in the blood and reducing the risk of cardiovascular diseases